News & Updates

Original New Drug Application Approvals by US FDA (16-31 March 2024)

04 Apr 2024

New drug applications approved by US FDA as of 16-31 March 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2024)

04 Apr 2024

Drinking less alcohol confers cardiovascular benefits among heavy drinkers

02 Apr 2024

Reducing alcohol consumption helps lower the risk of future adverse cardiovascular events, especially angina and ischaemic stroke, among people who drink heavily, according to a study.

Drinking less alcohol confers cardiovascular benefits among heavy drinkers

02 Apr 2024

Novel neutralizing mAb offers potential treatment for cerebral ischaemic injury

02 Apr 2024 by

Researchers from a joint team at the University of Hong Kong (HKU) and Chinese Academy of Sciences have developed a novel neutralizing monoclonal antibody (mAb; 6H2) that targets circulating adipocyte fatty acid–binding protein (A-FABP), offering potential in alleviating cerebral ischaemic injury.

Novel neutralizing mAb offers potential treatment for cerebral ischaemic injury

02 Apr 2024

Renal denervation affords durable BP control

02 Apr 2024

Renal denervation yields substantial reductions in ambulatory systolic blood pressure for up to 36 years in randomized controlled trials and up to 10 years in observational cohort studies without compromising renal function, according to the results of a systematic review and meta-analysis.

Renal denervation affords durable BP control

02 Apr 2024

Edoxaban matches apixaban for stroke prevention in very elderly population

01 Apr 2024

Very elderly patients with nonvalvular atrial fibrillation fare well with either edoxaban or apixaban in terms of stroke prevention, although those on edoxaban may have higher bleeding risk, according to a study.

Edoxaban matches apixaban for stroke prevention in very elderly population

01 Apr 2024

Add-on colchicine may help prevent pericarditis recurrence

23 Mar 2024

Adding colchicine to anakinra appears to work well in reducing the incidence of recurrent pericarditis, according to a study.

Add-on colchicine may help prevent pericarditis recurrence

23 Mar 2024

Liraglutide may prevent peripheral artery disease progression in type 2 diabetes

22 Mar 2024

In the treatment of patients with type 2 diabetes and peripheral artery disease (PAD), a 6-month course of liraglutide results in increased peripheral perfusion, according to the results of an open-label study.

Liraglutide may prevent peripheral artery disease progression in type 2 diabetes

22 Mar 2024

‘Planet-friendly’ foods help improve cardiovascular health in teens

20 Mar 2024

Eating “planet-friendly” foods may result in better cardiovascular (CV) health in adolescents, according to a study involving European participants.

‘Planet-friendly’ foods help improve cardiovascular health in teens

20 Mar 2024

Early recurrence in patients with post-CABG atrial fibrillation not a risk factor for mortality

13 Mar 2024

In patients with new-onset postoperative atrial fibrillation (POAF) following coronary artery bypass grafting (CABG), early AF recurrence is common but not associated with death, according to a study.

Early recurrence in patients with post-CABG atrial fibrillation not a risk factor for mortality

13 Mar 2024

Alogliptin ups risk of heart failure exacerbation in T2D patients

13 Mar 2024

In type 2 diabetes (T2D) patients with established heart failure (HF), use of alogliptin appears to contribute to an increased risk of HF exacerbation, reveals a study.

Alogliptin ups risk of heart failure exacerbation in T2D patients

13 Mar 2024

News & Updates

Filter by Specialty:

Specialty:

Original New Drug Application Approvals by US FDA (16-31 March 2024)

Original New Drug Application Approvals by US FDA (16-31 March 2024)

Drinking less alcohol confers cardiovascular benefits among heavy drinkers

Drinking less alcohol confers cardiovascular benefits among heavy drinkers

Novel neutralizing mAb offers potential treatment for cerebral ischaemic injury

Novel neutralizing mAb offers potential treatment for cerebral ischaemic injury

Renal denervation affords durable BP control

Renal denervation affords durable BP control

Edoxaban matches apixaban for stroke prevention in very elderly population

Edoxaban matches apixaban for stroke prevention in very elderly population

Add-on colchicine may help prevent pericarditis recurrence

Add-on colchicine may help prevent pericarditis recurrence

Liraglutide may prevent peripheral artery disease progression in type 2 diabetes

Liraglutide may prevent peripheral artery disease progression in type 2 diabetes

‘Planet-friendly’ foods help improve cardiovascular health in teens

‘Planet-friendly’ foods help improve cardiovascular health in teens

Early recurrence in patients with post-CABG atrial fibrillation not a risk factor for mortality

Early recurrence in patients with post-CABG atrial fibrillation not a risk factor for mortality

Alogliptin ups risk of heart failure exacerbation in T2D patients

Alogliptin ups risk of heart failure exacerbation in T2D patients